Compare Tenet Healthcare Corporation (THC) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Under Armour Inc Class A — how do they compare? Tenet Healthcare Corporation trades at $269.36 (market cap $21.67B), while Under Armour Inc Class A trades at $4.82 (market cap $2.08B). The key difference: Tenet Healthcare Corporation is far larger — about 10.4× Under Armour Inc Class A's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| THC | UA | |
|---|---|---|
Market Cap | $21.67B | $2.08B |
Sector | Health | Consumer Cyclical |
52-Week High | $280.77 | $7.88 |
52-Week Low | $161.37 | $3.96 |
Enterprise Value | $32.74B | $3.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.06, down 2.26% today, with a bearish technical signal but strong fundamentals. The stock shows robust profitability with an 82.83% gross margin and 53.31% ROE, supported by three consecutive quarterly EPS beats. Recent news includes a $2 billion senior notes offering for refinancing and participation in the Wells Fargo Healthcare Conference, highlighting active capital management and investor engagement.
Outlook remains positive due to undervaluation (P/E 10.4 vs. industry) and a $281.44 consensus price target, though risks include negative net cash flow and high debt. Analyst sentiment is strongly bullish with 81% buy ratings, but technical weakness near support at $256 may signal short-term pressure.
Under Armour (UA) trades at $4.95, down 3.32% today, reflecting ongoing challenges. The stock is technically bearish with weak moving averages, while fundamentals show revenue declining to $5.16B in 2025 and a net loss of -$201.27M. Negative cash flow and high debt levels add pressure, though a P/S ratio of 0.42 suggests potential undervaluation. Recent news highlights continued revenue declines and lowered guidance, signaling brand and demand headwinds.
The outlook remains cautious due to persistent losses and competitive pressures. While analyst sentiment is mixed with 40% buy ratings, risks from execution missteps and weak consumer demand outweigh near-term opportunities. Investors should focus on margin improvement and debt management for any sustainable recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
